News

Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi (1940-2024)

Parma, March 5th, 2024 - Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi, a fundamental pillar of the company who shaped its history alongside his brother Alberto.Born in...

1/21

Chiesi Global Rare Diseases Announces Publication of Results from Phase 3 BALANCE Study in Fabry Disease

2/21

Chiesi’s 2022 Sustainability Report: “Purpose First”

3/21

ARCHIVE NEWS

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

17 May 2023 NEWS

2022 for Chiesi: The Group’s international growth continues

17 April 2023 NEWS

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

14 March 2023 NEWS

Chiesi appoints Giuseppe Accogli as new Group CEO

01 February 2023 NEWS

Chiesi accelerates path toward full sustainability despite Covid-19 pandemic

23 June 2021 NEWS

World Asthma Day 2021: Press release

05 May 2021 NEWS

CHIESI CONTINUES CULTURAL TRANSFORMATION WITH NEW VISUAL IDENTITY THAT MIRRORS PATIENTS’ LANGUAGE AND EXPERIENCES

22 March 2021 NEWS

Chiesi Group: performance is up in 2020

09 March 2021 NEWS

European market authorisation for the extrafine triple combination therapy

05 February 2021 NEWS

COLLABORATION BETWEEN KAIA HEALTH AND CHIESI GROUP

30 November 2020 NEWS

COPD Day 2020

17 November 2020 NEWS

Collaboration between Moderna and Chiesi Group

17 September 2020 NEWS

10 Years Chiesi Belgium

02 September 2020 NEWS

Chiesi publishes its annual report

23 July 2020 NEWS

Climbing For Life

09 June 2020 NEWS

Zondag 31 mei - Werelddag zonder tabak

30 May 2020 NEWS

Domus Medica SSMG

07 April 2020 NEWS

Chiesi Belgium & COVID-19 Pandemic

03 April 2020 NEWS

Telecomlaan / Avenue Telecom 9 PO Box 4 1831 Diegem
Belgium
T +32 (0)2 788 42 00
info.be@chiesi.com
Approval n°: 1381/TCP/InfoBrochure/BE/03-2023
Latest update: 08/02/2024

CHIESI ON THE WEB